Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by BehStreet on May 20, 2020 12:26pm
74 Views
Post# 31051864

RE:RE:RE:Shall be great day tomorrow for c.AGN :)

RE:RE:RE:Shall be great day tomorrow for c.AGN :)Well considering we had a pp closing at .35c, and that we have created a very nice base of support in the .33-.35c range, and the fact that volume is so low (on both the buy and sell side), and that management indicated last week that IND application news will be out shortly, I'd say that buying here is a logical move. As to manage risk, if you plan on buying, I'd recommend buying in increments as nobody can predict the day to day price moves. JMO. Hope this helps.

Moose87 wrote: I bought into NUMI for $1.05 @ $5000. Totally forgot about it until today. I have up to $45K more to throw. Recommend a purchase at this price? Need a balanced opinion here not just positives. 


<< Previous
Bullboard Posts
Next >>